Cardiac Science CORP (CSCX) is a publicly traded company in the Unknown sector. Across all available filings, 22 corporate insiders have executed 120 transactions totaling $1.1M, demonstrating a bearish sentiment with -$968.3K in net insider flow. The most recent transaction on Dec 3, 2010 involved a transaction of 2,247 shares valued at $5.2K.
No significant insider buying has been recorded for CSCX in the recent period.
No significant insider selling has been recorded for CSCX in the recent period.
Based on recent SEC filings, insider sentiment for CSCX is bearish with an Insider Alignment Score of 5/100 and a net flow of -$968.3K. Insiders are reducing their positions, though this can be driven by factors unrelated to company outlook.
Insider trading at Cardiac Science CORP (CSCX) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 22 insiders are actively trading CSCX stock, having executed 120 transactions in the past 90 days. The most active insider is Frank H. Pearl (Executive), who has made 10 transactions totaling $555.9K.
Get notified when executives and directors at CSCX file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| Dec 3, 2010 | H. Browne Noreen | Executive | Disposition | 2,247 | $2.30 | $5.2K | |
| Dec 3, 2010 | J. Ford Alfred | Executive | Disposition | 1,654 | $2.30 | $3.8K | |
| Dec 3, 2010 | Lemvigh Kurt | Executive | Disposition | 525 | $2.30 | $1.2K | |
| Dec 3, 2010 | L. Marver David | Executive | Disposition | 14,315 | $2.30 | $32.9K | |
| Dec 3, 2010 | K. Matysik Michael | Executive | Disposition | 6,895 | $2.30 | $15.9K | |
| Dec 3, 2010 | W. Odell Robert | Executive | Disposition | 5,581 | $2.30 | $12.8K | |
| Dec 3, 2010 | J. Thompson Barbara | Executive | Disposition | 3,513 | $2.30 | $8.1K | |
| Dec 3, 2010 | A. Titus Ralph | Executive | Disposition | 1,838 | $2.30 | $4.2K | |
| Dec 2, 2010 | H. Browne Noreen | Executive | Option Exercise | 2,500 | $N/A | $0 | |
| Dec 2, 2010 | H. Browne Noreen | Executive | Payment | 778 | $2.29 | $1.8K | |
| Dec 2, 2010 | J. Ford Alfred | Executive | Payment | 846 | $2.29 | $1.9K | |
| Dec 2, 2010 | J. Ford Alfred | Executive | Option Exercise | 2,500 | $N/A | $0 | |
| Dec 2, 2010 | L. Marver David | Executive | Option Exercise | 18,750 | $N/A | $0 | |
| Dec 2, 2010 | L. Marver David | Executive | Payment | 4,960 | $2.29 | $11.4K | |
| Dec 2, 2010 | K. Matysik Michael | Executive | Option Exercise | 9,375 | $N/A | $0 |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Sale(S) | 31 | $1.0M | 56.4% |
Tender(U) | 12 | $458.1K | 25.1% |
Exercise(M) | 49 | $128.1K | 7.0% |
Disposition(D) | 9 | $85.7K | 4.7% |
Payment(F) | 16 | $64.8K | 3.6% |
Purchase(P) | 3 | $58.8K | 3.2% |
Insider selling pressure at Cardiac Science CORP has increased, with 22 insiders executing 120 transactions across all time. Total sales of $1.0M significantly outpace purchases of $58.8K, resulting in a net outflow of $968.3K. This selling activity appears largely discretionary, which may warrant closer attention from investors.